Our guest in this podcast episode is Sreekanth Gopi, a leader in generative AI and machine learning. Sreekanth has applied AI to fields as diverse as physiological monitoring, meditation, and even generating multi-track Indian classical music. He’s published award-winning research on EEG spectral analysis and adaptive quiz generation using large language models, participated in over 12 AI hackathons—winning two—and is now a Prompt Engineer at Morgan Stanley, where he fine-tunes cutting-edge LLM interactions for real-world applications.

In this episode we explore how AI is redefining stress management and revolutionizing real-time physiological data applications.  Tune in to learn about the world of generative artificial intelligence— and looking at its transformative potential in mental health and stress management.

From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi

Dr. Thomas Chen is a world-renowned neurosurgeon, Director of Surgical Neuro-Oncology at the University of Southern California, and the founder and CEO of NeOnc Technologies. In this podcast episode we discuss the company’s unique approach to treating glioblastoma and other aggressive brain cancers.  

New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc

In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer

The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

Gene therapy offers significant hope for treating sickle cell disease (SCD), a genetic disorder caused by a single mutation in the hemoglobin gene. Recent advancements have led to promising developments and FDA approvals, but challenges remain.  In this podcast episode, gene therapy survivor, Jimi Olaghere, shares his journey and offers hope to others with his inspirational message and through his advocacy for patients in the sickle cell community.  

From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere

AI is transforming job search, recruiting and hiring practices.  Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group.  Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry.  In this episode Steve shares his insights on how AI is transforming the hiring process.

How AI is Transforming Job Search and Recruiting in Life Sciences and Technology

Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts.  In this episode, Brad shares his personal story battling lymphoma at the young age of 29 along with his experience receiving an innovative cell therapy.  This field is transforming lives and Brad is living proof of this potential.  

Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt

In this podcast episode, Dr. Kilian Kelly, CEO of Cynata Therapeutics, discusses the future of regenerative medicine!  Discover how mesenchymal stem cells (MSCs)—powerful cells that repair and regenerate tissues—are revolutionizing treatments for a range of diseases. Dr. Kelly shares insights on Cynata’s groundbreaking Cymerus™ platform and the exciting potential of MSC therapies. 

How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly

Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies.  

In this episode, Dan Schmitt, President and CEO of Actuate Therapeutics, shares how elraglusib, an investigational targeted therapy, may provide a new option for patients with metastatic pancreatic cancer.  We explore the urgent unmet need and why Dan thinks this could be a turning point for one of oncology's toughest challenges.  

Hope in Hard Places:  A Potential New Option for Patients with Pancreatic Cancer

Early cancer detection doesn't have to mean invasive tests.  In this podcast episode, we sit down with Jeff Bousfield, CEO of Nonacus Cancer Diagnostics, to explore how his UK-based company is revolutionizing precision cancer diagnostics with a powerful suite of non-invasive tools.  Jeff shares the human story behind the science and why he believes the future of cancer care starts with precision diagnostics tools that are faster, less invasive, and more accessible to patients.  

How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield

In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.

Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need.  The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. 

To learn more about Advanced Therapies, visit our Knowledge Base:  https://www.advancedtherapiesconnect.ai/knowledge-base

To find a specialist at an advanced therapy treatment center, visit our Advanced Therapy AI-powered referral tool here:  https://www.advancedtherapiesconnect.ai/

To learn more about Genoplex, please visit https://www.genoplex.ai

How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield

Rx for Biotech

Related tracks